The Food and Drug Administration on Thursday approved Qiagen's fourth generation tuberculosis blood test.
Here are three things to know.
- The Quantiferon-TB Gold Plus test is designed to detect latent tuberculosis in patients.
- The blood test offers a broad look into an individual's immune response to tuberculosis, according to a news release.
- Qiagen plans to launch the new test later this year.
More articles on supply chain:
7 drugmakers in the headlines
4 ways hospitals can lower inpatient drug costs
6 must-reads for supply chain leaders this week